Literature DB >> 21691110

TGR5 sequence variation in primary sclerosing cholangitis.

Johannes R Hov1, Verena Keitel, Erik Schrumpf, Dieter Häussinger, Tom H Karlsen.   

Abstract

TGR5, the G-protein-coupled bile acid receptor 1 (GPBAR1), has been linked to inflammatory pathways and homeostasis, and could therefore be involved in primary sclerosing cholangitis (PSC), a chronic inflammatory bile duct disease associated with ulcerative colitis (UC). In addition, the TGR5 gene is localized at chromosome 2q35, close to a genetic variant associated with both PSC and UC in recent genome-wide association studies. This provided a strong rationale for a recent study searching for novel genetic variants of TGR5 in PSC. In the study, resequencing of TGR5 was performed in 267 PSC patients and 274 healthy controls. Six nonsynonymous mutations were identified in addition to 16 other novel single-nucleotide polymorphisms. In experimental studies, five of the nonsynonymous mutations were found to reduce or abolish TGR5 function by affecting localization or activity. Fine-mapping of the chromosome 2q35 locus in large patient panels revealed an overall association between a common TGR5 single-nucleotide polymorphism and PSC and UC, but strong linkage disequilibrium precluded demarcation of TGR5 from neighboring genes. In conclusion, the data from the experimental evaluation of novel nonsynonymous mutations represent an important insight into the structural biology of TGR5. In addition, the combination of the known roles of the receptor, the genetic associations and the mutations which affect receptor function, suggests that TGR5 variation may contribute to PSC and UC susceptibility. However, this conclusion needs to be strengthened in further research.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21691110     DOI: 10.1159/000324138

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  8 in total

Review 1.  Management of primary sclerosing cholangitis: conventions and controversies.

Authors:  Natasha Chandok; Gideon M Hirschfield
Journal:  Can J Gastroenterol       Date:  2012-05       Impact factor: 3.522

Review 2.  GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation.

Authors:  T Lieu; G Jayaweera; N W Bunnett
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 3.  The bile acid TGR5 membrane receptor: from basic research to clinical application.

Authors:  Henri Duboc; Yvette Taché; Alan F Hofmann
Journal:  Dig Liver Dis       Date:  2014-01-09       Impact factor: 4.088

Review 4.  Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract.

Authors:  Nigel W Bunnett
Journal:  J Physiol       Date:  2014-03-10       Impact factor: 5.182

5.  Probing the Binding Site of Bile Acids in TGR5.

Authors:  Antonio Macchiarulo; Antimo Gioiello; Charles Thomas; Thijs W H Pols; Roberto Nuti; Cristina Ferrari; Nicola Giacchè; Francesca De Franco; Mark Pruzanski; Johan Auwerx; Kristina Schoonjans; Roberto Pellicciari
Journal:  ACS Med Chem Lett       Date:  2013-10-15       Impact factor: 4.345

6.  Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients.

Authors:  Adam Weizman; Brian Huang; Dror Berel; Stephan R Targan; Marla Dubinsky; Phillip Fleshner; Andrew Ippoliti; Manreet Kaur; Deepa Panikkath; Steve Brant; Ioannis Oikonomou; Rick Duerr; John Rioux; Mark Silverberg; Jerome I Rotter; Eric Vasiliauskas; Talin Haritunians; David Shih; Dalin Li; Gil Y Melmed; Dermot P B McGovern
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

7.  Obesity and developmental delay in a patient with uniparental disomy of chromosome 2.

Authors:  T Yu; J Li; N Li; R Liu; Y Ding; G Chang; Y Chen; Y Shen; X Wang; J Wang
Journal:  Int J Obes (Lond)       Date:  2016-09-22       Impact factor: 5.095

8.  Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis.

Authors:  Yung-Yi Chen; Kathryn Arndtz; Gwilym Webb; Margaret Corrigan; Sarah Akiror; Evaggelia Liaskou; Paul Woodward; David H Adams; Chris J Weston; Gideon M Hirschfield
Journal:  JHEP Rep       Date:  2019-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.